Access cutting-edge blood clots treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access blood clots specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related blood clots treatment provided free
This study is researching 2 different experimental drugs called REGN9933 and REGN7508 (called "study drugs"). The study is focused on adults undergoing a placement of a catheter in the vein, also called a 'PICC line'. The aim of the study is to see how effective the study drug is at preventing venous thromboembolism (VTE) and other related disease after catheter placement. The study is looking at several other research questions, including: * What side effects may happen from taking the study
Sponsor: Regeneron Pharmaceuticals
Check if you qualify for this blood clots clinical trial in New York, NY
If you're searching for blood clots treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced blood clots specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.